期刊文献+

某三甲医院细菌耐药监测分析 被引量:2

Analysis on antimicrobial resistance surveillance in a Class A tertiary hospital
下载PDF
导出
摘要 目的分析安徽医科大学第一附属医院细菌耐药性监测的情况,控制多重耐药菌院内感染流行暴发,保障抗菌药物临床有效治疗。方法收集2020年1—12月微生物检验科接收感染类患者的血液、尿液、粪便、呼吸道分泌液等标本进行微生物检验和细菌耐药性监测工作。结果共计分离出11651株致病菌株,其中革兰氏阳性菌和革兰氏阴性菌分别占27.8%和72.2%。分离率占前三位的是大肠埃希菌占21.1%,肺炎克雷伯菌占14.2%,金黄色葡萄球菌占9.9%,碳氢酶烯耐药铜绿假单胞菌基本与CHINET水平一致;鲍曼不动杆菌细菌耐药率高于CHINET水平。结论该院细菌耐药形势较严峻,须根据细菌耐药监测结果指导临床合理使用抗菌药物,同时应结合医院感染预防控制措施,才能有效控制耐药细菌的流行播散。 Objective To analyze the situation of antimicrobial resistance surveillance in the First Affiliated Hospital of Anhui Medical University,in order to control the epidemic outbreak of nosocomial infections with multi-antibiotic resistant bacteria and ensure effective clinical treatment with antimicrobial drugs.Methods Blood,urine,stool and respiratory secretion specimens from infected patients admitted to the Microbiology Laboratory from January to December 2020 were collected for microbiological testing and antimicrobial resistance surveillance.Results A total of 11651 pathogenic strains were isolated,of which Gram-positive and Gramnegative bacteria accounted for 27.8%and 72.2%,respectively.The three pathogenic strains with the highest isolation rate were Escherichia coli(21.1%),Klebsiella pneumoniae(14.2%)and Staphylococcus aureus(9.9%).The level of hydrocarbon resistant Pseudomonas aeruginosa is basically consistent with that of CHINET;The resistance rate of Acinetobacter baumannii was higher than that of CHINET.Conclusion This hospital is facing serious antimicrobial resistance.To effectively control the epidemic spread of antibiotic-resistant bacteria,the clinical use of antimicrobial drugs must be guided according to the results of antimicrobial resistance surveillance,and hospital infection prevention and control measures should be taken at th e same time.
作者 邵宜波 顾有为 SHAO Yibo;GU Youwei(Department of Infection Management,the First Affiliated Hospital of Anhui Medical University,Anhui,Hefei 230022,China)
出处 《中国医药科学》 2023年第12期9-12,共4页 China Medicine And Pharmacy
基金 国家自然科学基金面上项目(62072003)。
关键词 细菌 耐药性 监测 抗菌药物 Bacteria Resistance Surveillance Antimicrobial drugs
  • 相关文献

参考文献6

二级参考文献43

  • 1曹文庄,张晓丹.从药品注册的实践谈合理使用抗菌药的重要意义[J].中国药学杂志,2004,39(11):801-803. 被引量:46
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. MI00-S22. Wayne, PA:CLSI,2012.
  • 3European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version I. I, 2010-04-27.
  • 4Jones RN, Ferraro MJ, Reller LB, et al. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.J Clin Microbiol,2007 ,45 :227-230.
  • 5Fernrindez-Mazarrasa C, Mazarrasa 0, CalvoJ, et al. High concerntration of mananese in Mueller-Hinton agar increase MICs of tigecyc:line determined by Etest.J Clin Microbiol, 2009, 47: 827-829.
  • 6Bradford PA, Petersen PJ, Young M, et al. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob Agents Chemother ,2005,49 :3903-3909.
  • 7Curcio D, Fernandez F. Comment on: Effect of different Mueller?Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.J Antimicrob Chemother ,2008,62: 1166-1167.
  • 8Casal M, Rodriguez F,Johnson B, et al. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-nan-susceptible Acinetobacter spp.J Antimicrob Chemather, 2009, 64:69-72.
  • 9Zarkotou 0, Pournaras S, Altouvas G, et al. Comparative evaluation of tigecycline susceptibility testing methods far expanded-spectrum cephalosporin and carbapenem-resistant gram?negative pathogens.J Clin Microbiol, 2012, 50 :3747-3750.
  • 10LiuJW, Ko WC, Huang CH, et al. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010. Antimicrob Agents Chemother, 2012, 56:1414-1417.

共引文献264

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部